EMA Updates Pre-Authorization Procedural Advice To Cover Joint Clinical Assessments
Executive Summary
Two new pieces of guidance, from the EMA and the HTA coordination group respectively, should help companies understand which drugs must undergo an EU-wide joint clinical assessment and how to notify the relevant authorities about them.